So, that’s again why we probably, in the long run, will benefit from both sides, we get better models by understanding the biology better, maybe also at some point the models will teach us more about the biology. But again, right now we are still at the earlier end, but again, if we know the downstream tasks, or if we just want to have utility, that’s where we get quite well, basically. But then, to use it really as a longer-term vision, as a research platform, that we can release the data really without concerns, I think therefore we need to be a little more realistic, and that’s what we have right now, at least for these domains